GNAQ/11 mutations in uveal melanoma: is YAP the key to targeted therapy?

Abstract excerpt

GNAQ and GNA11 are frequently mutated in uveal melanoma, but they remain difficult therapeutic targets. In this issue of Cancer Cell, Feng and colleagues and Yu and colleagues demonstrate that the oncogenic activity of mutant GNAQ/11 is mediated at least in part through YAP, potentially uncovering a new therapeutic strategy.

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to GTP-Binding Protein alpha Subunits
• Share to GTP-Binding Protein alpha Subunits, Gq-G11
• Share to GTP Phosphohydrolases